With the advancement of treatments for people living with HIV (PLWH), having a longer lifespan requires clinicians to balance treatment for HIV with other comorbid or chronic conditions associated with aging. For example, people aging with HIV (PAWH) show higher risks of cardiovascular disease and certain types of cancers compared to those without HIV. It is common for PAWH to follow multiple medication treatments (polypharmacy) for their HIV and other chronic conditions. Clinicians treating PAWH need to understand the interactions of the conditions, the polypharmacy or various medications prescribed, and work with one another as a team to best treat these patients and meet their unique health care needs.
This CMEO BriefCase entitled, Team Approach to Addressing Comorbidities in Aging Populations of People Living With HIV (PLWH), will discuss a specific case of an individual facing the challenges of living with HIV and having other comorbid or chronic conditions as a matter of aging. Expert faculty will discuss a team-based approach to caring for PAWH, including how to balance the various treatments and polypharmacy for HIV and other common conditions associated with aging.
Utilize team-based interdisciplinary care to optimize HIV and comorbidity outcomes in aging patients.
This program has been supported by an independent educational grant from Gilead Sciences, Inc.
Primary care physicians, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists specializing in HIV.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process.
Dr. Malvestutto reports the following financial relationships: Advisory Board: Gilead Sciences, Inc.; ViiV Healthcare; and Pfizer Inc. Research Support: Lilly.
Dr. Murray reports the following financial relationships: Advisory Board: Janssen Pharmaceuticals, Inc. and ViiV Healthcare. Speakers Bureau: Gilead Sciences, Inc.; Merck & Co., Inc.; and ViiV Healthcare.
Disclosures were obtained from the CME Outfitters, LLC staff; no disclosures to report:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Call us at 877.CME.PROS (877.263.7767).